Florida Cancer Specialists & Research Institute, LLC (FCS), a consistent top performer among the 126 U.S.-based oncology practices that participated in the Center for Medicare & Medicaid Innovation (CMMI) Oncology Care Model (OCM), shares its results in the payment and delivery model’s final wave which ended in June 2022 in a newly released case study.
Research conducted through the Florida Cancer Specialists & Research Institute were featured recently at two global gatherings sponsored by the American Society of Clinical Oncology (ASCO®).
Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Hitesh Patel, MD has joined its Executive Board, effective January 27, 2023.
Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes Board-certified hematologist and medical oncologist Pavankumar Tandra, MD to the statewide practice. He is providing care to patients at the Sarasota Downtown clinic located at 1970 Golf Street, Sarasota, FL 34236.
FCS Top News Updates
FCS Expands Footprint Into St. Lucie County, Breaks Ground For New Cancer Center in Tradition
FCS a Top Performer in the Center for Medicare & Medicaid Innovation’s Oncology Care ModelFlorida Cancer Specialists & Research Institute, LLC (FCS), a consistent top performer among the 126 U.S.-based oncology practices that participated in the Center for Medicare & Medicaid Innovation (CMMI) Oncology Care Model (OCM), shares its results in the payment and delivery model’s final wave which ended in June 2022 in a newly released case study.
Study shows women with low-risk breast cancer could skip postop radiationA recently published study provides data to support that certain patients can achieve positive outcomes without postoperative radiation.
New Findings in the Diagnosis and Treatment of Gastrointestinal and Genitourinary CancersResearch conducted through the Florida Cancer Specialists & Research Institute were featured recently at two global gatherings sponsored by the American Society of Clinical Oncology (ASCO®).
New Targeted Drug for Patients with Mantle Cell LymphomaFDA approved the first Non-Covalent (Reversible) BTK inhibitor for the treatment of Relapsed or Refractory Mantle Cell Lymphoma in adult patients.
Successful Lifestyle Change: Action & AccountabilityIt’s that time of year again! The time by which 80% of New Year’s Resolutions have failed. What to do if you find yourself in that statistic? Read on!
FCS Appoints Hitesh Patel, MD to Executive BoardFlorida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Hitesh Patel, MD has joined its Executive Board, effective January 27, 2023.
Breast Cancer Diagnosis Announced by Peloton® InstructorPopular cycling instructor Leanne Hainsby revealed last weekend in an Instagram post that she is undergoing treatment for breast cancer.
Pavan Kumar Tandra, MD Joins FCS in SarasotaFlorida Cancer Specialists & Research Institute, LLC (FCS) welcomes Board-certified hematologist and medical oncologist Pavankumar Tandra, MD to the statewide practice. He is providing care to patients at the Sarasota Downtown clinic located at 1970 Golf Street, Sarasota, FL 34236.